WebVAL-083 is a "first-in-class" small molecule chemotherapeutic. Its unique structure provides many valuable benefits, including the targeting of DNA for its therapeutic effect and its ability to cross the blood brain barrier, critical for activity against central nervous system (CNS) tumors. VAL-083 has completed Pre-Clinical, Phase I and II ... WebPress Releases. Vera Therapeutics to Participate in the Cowen 43rd Annual Health Care Conference. February 27, 2024.
KERA THERAPEUTICS, INC in Medfield, MA Company Info
WebExplore Kera Therapeutics's investment information, scientific platforms, therapeutic approaches, indications ... Explore Kera Therapeutics's investment information, … Web17 sep. 2024 · KERA THERAPEUTICS, INC. Company Number. 001459497. Status. Inactive. Incorporation Date. 17 September 2024 (over 2 years ago) Dissolution Date. 4 … sunova koers
Cara Therapeutics Announces Late-Breaking Presentation at 2024 …
WebTango Therapeutics 201 Brookline Ave, Suite 901 Boston, MA 02215 Tel: +1-857-320-4900. Contact; Careers ... WebView Kera Therapeutics Inc. revenue, competitors and contact information. Find and reach Kera Therapeutics Inc.'s employees by department, seniority, title, and much more. … WebGov. Greg Abbott and other conservatives say families need options to escape “woke” education in public schools. East Texas parents and school leaders say the national … sunova nz